Anni Winckelmann

1.3k total citations · 1 hit paper
20 papers, 938 citations indexed

About

Anni Winckelmann is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Anni Winckelmann has authored 20 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Anni Winckelmann's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Anni Winckelmann is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). Anni Winckelmann collaborates with scholars based in Denmark, United States and Australia. Anni Winckelmann's co-authors include Sarah Palmer, Lars Østergaard, Ole S. Søgaard, Martin Tolstrup, Thomas A. Rasmussen, Rikke Olesen, Mathias Lichterfeld, Sharon R. Lewin, Kirston Barton and María J. Buzón and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anni Winckelmann

19 papers receiving 930 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

2014 472 citations Thomas A. Rasmussen, Martin Tolstrup et al. The Lancet HIV profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anni Winckelmann Denmark	12	718	544	310	198	154	20	938
Judith Dalmau Spain	15	705 1.0×	471 0.9×	385 1.2×	158 0.8×	162 1.1×	29	940
Matthew Pace United Kingdom	17	830 1.2×	503 0.9×	387 1.2×	193 1.0×	188 1.2×	33	1000
Jérémie Prévost Canada	22	684 1.0×	660 1.2×	522 1.7×	183 0.9×	193 1.3×	57	1.2k
Abigail Liberty United States	8	914 1.3×	631 1.2×	317 1.0×	245 1.2×	198 1.3×	17	1.2k
Subul Beg United States	12	1.1k 1.5×	754 1.4×	405 1.3×	132 0.7×	201 1.3×	15	1.2k
Jennifer M. Zerbato Australia	15	495 0.7×	321 0.6×	266 0.9×	150 0.8×	143 0.9×	25	662
Carolina Garrido United States	13	554 0.8×	289 0.5×	355 1.1×	157 0.8×	213 1.4×	20	770
Katherine Perkey United States	7	698 1.0×	452 0.8×	290 0.9×	80 0.4×	169 1.1×	9	857
Natalia Soriano-Sarabia United States	17	760 1.1×	408 0.8×	555 1.8×	144 0.7×	268 1.7×	42	1.1k
Björn D. Kuhl Canada	13	680 0.9×	357 0.7×	460 1.5×	192 1.0×	167 1.1×	14	896

Countries citing papers authored by Anni Winckelmann

Since Specialization

Citations

This map shows the geographic impact of Anni Winckelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anni Winckelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anni Winckelmann more than expected).

Fields of papers citing papers by Anni Winckelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anni Winckelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anni Winckelmann. The network helps show where Anni Winckelmann may publish in the future.

Co-authorship network of co-authors of Anni Winckelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anni Winckelmann. A scholar is included among the top collaborators of Anni Winckelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anni Winckelmann. Anni Winckelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winckelmann, Anni, Ulrik Fahnøe, Alexander P. Underwood, et al.. (2025). Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes. Viruses. 17(5). 684–684.

Winckelmann, Anni, et al.. (2023). The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection. Viruses. 15(5). 1141–1141. 8 indexed citations

Underwood, Alexander P., Carlota Fernandez-Antunez, Lotte S. Mikkelsen, et al.. (2023). Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination. EBioMedicine. 89. 104475–104475. 12 indexed citations

Johannessen, Asgeir, Dag Henrik Reikvam, Soo Aleman, et al.. (2023). The Nuc-Stop study: an open-label, randomized trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B patients. Journal of Hepatology. 78. S1150–S1151. 1 indexed citations

Winckelmann, Anni, Ulrik Fahnøe, Andreas Lundh, et al.. (2022). Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment. Journal of Clinical Virology. 150-151. 105159–105159. 8 indexed citations

Underwood, Alexander P., Carlota Fernandez-Antunez, Lotte S. Mikkelsen, et al.. (2022). Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines. Vaccines. 10(1). 75–75. 13 indexed citations

Underwood, Alexander P., Carlota Fernandez-Antunez, Anni Winckelmann, et al.. (2021). Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19. EBioMedicine. 71. 103519–103519. 16 indexed citations

Lassaunière, Ria, Jannik Fonager, Morten Rasmussen, et al.. (2021). In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms. Frontiers in Microbiology. 12. 698944–698944. 26 indexed citations

Ronit, Andreas, et al.. (2021). Reactive Infectious Mucosal Eruptions (RIME) Secondary to Chlamydia pneumoniae Infection. SHILAP Revista de lepidopterología. 4(2). 11–11. 2 indexed citations

10.

Vibholm, Line K., Mariane Høgsbjerg Schleimann, Giacomo S. Frattari, et al.. (2019). Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals. AIDS. 33(8). 1315–1325. 71 indexed citations

11.

Winckelmann, Anni, Wei Shao, Mariane Høgsbjerg Schleimann, et al.. (2018). Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals. AIDS. 32(13). 1793–1802. 9 indexed citations

12.

Winckelmann, Anni, Kirston Barton, Bonnie Hiener, et al.. (2017). A5 Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin. Virus Evolution. 3(suppl_1). 1 indexed citations

13.

Winckelmann, Anni, Kirston Barton, Bonnie Hiener, et al.. (2017). Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS. 31(6). 771–779. 28 indexed citations

14.

Barton, Kirston, Anni Winckelmann, & Sarah Palmer. (2016). HIV-1 Reservoirs During Suppressive Therapy. Trends in Microbiology. 24(5). 345–355. 94 indexed citations

15.

Barton, Kirston, Bonnie Hiener, Anni Winckelmann, et al.. (2016). Broad activation of latent HIV-1 in vivo. Nature Communications. 7(1). 12731–12731. 60 indexed citations

16.

Højen, Jesper Falkesgaard, Thomas A. Rasmussen, Anni Winckelmann, et al.. (2015). Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir. Molecular Medicine. 21(1). 337–345. 28 indexed citations

17.

Rasmussen, Thomas A., Martin Tolstrup, Christel R. Brinkmann, et al.. (2014). Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. The Lancet HIV. 1(1). e13–e21. 472 indexed citations breakdown →

18.

Winckelmann, Anni, Thomas A. Rasmussen, Jesper Melchjorsen, et al.. (2013). Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients. PLoS ONE. 8(4). e62074–e62074. 44 indexed citations

19.

Rasmussen, Thomas A., Martin Tolstrup, Anni Winckelmann, Lars Østergaard, & Ole S. Søgaard. (2013). Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials. Human Vaccines & Immunotherapeutics. 9(4). 790–799. 39 indexed citations

20.

Winckelmann, Anni, et al.. (1987). Adenosine Triphosphate Levels in Human Spermatozoa. Archives of Andrology. 18(3). 183–188. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact